About Us - AelisFarma

Management Team

”

In a mere 8 years we have developed two clinical drug candidates and built an innovative and efficient research platform. Our secret: a new pharmacological class, an innovative approach to drug development, and the utmost dedication of our team.

“

Pier Vincenzo

Piazza

CEO

”

At Aelis Farma, we have one goal: transform innovation into reliable therapeutic solutions for diseases with unmet medical needs.

“

Stéphanie

Monlezun

COO

Corporate Team

Marie Line

Lefevre

Head of Finance

Léa

Floquet

Head of Legal

Key R&D Team

Sandy

Fabre

Head of Discovery and IP Leader

Aurélie

Boucard

Head of Preclinical Development

Helle

Mengel

Head of Clinical Development

Corinne

Chaimbault

Head of Pharmaceutical Development

Board of Directors

Anders Gersel

Pedersen

Chairman of the Board

Pier Vincenzo

Piazza

Director and CEO

Brahim

Guetarni

Director

Karina

Hansen

Independent Director

Karen

Linehan

Independent Director

Irina

Staatz-Granzer

Independent Director

François

Thomas

Non-voting Director

Scientific Advisory Board

Robert Malenka

Chairman of the Scientific Advisory Board

Professor and Deputy Director of the Neurosciences Institute (Stanford University)

Keith Humphreys

Professor and Section Director for Mental Health Policy, Department of Psychiatry (Stanford University)

Daniele Piomelli

Professor at the University of California Irvine (UCI), Former Director of Drug Discovery and Development IIT

Markus Heilig

Director, Center for Social and Affective Neuroscience, Linköping University (Sweden) Former Clinical Research Director at NIAAA within America’s National Institute of Health (NIH)